Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 29, 2020 - Issue 7
Submit an article Journal homepage
3,376
Views
12
CrossRef citations to date
0
Altmetric
EDITORIAL

Emerging therapies for COVID-19 pneumonia

Denise Battaglinia Anesthesia and Intensive Care, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy;b Department of Medicine, University of Barcelona (UB), Barcelona, SpainView further author information
,
Chiara Robbaa Anesthesia and Intensive Care, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, ItalyView further author information
,
Lorenzo Balla Anesthesia and Intensive Care, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy;c Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, ItalyView further author information
,
Fernanda Ferreira Cruzd Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilView further author information
,
Pedro Leme Silvad Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;e National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, BrazilView further author information
,
Paolo Pelosia Anesthesia and Intensive Care, Ospedale Policlinico San Martino, IRCCS for Oncology and Neurosciences, Genoa, Italy;c Department of Surgical Sciences and Integrated Diagnostic (DISC), University of Genoa, Genoa, ItalyView further author information
&
Patricia Rieken Macedo Roccod Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil;e National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, BrazilCorrespondence[email protected]
View further author information
 show all
Pages 633-637 | Received 26 Apr 2020, Accepted 17 May 2020, Published online: 01 Jun 2020

References

  • Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19). JAMA. 2020. DOI:10.1001/jama.2020.6019
  • Vaduganathan M, Vardeny O, Michel T, et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Eng J Med. 2020;382(17):1653–1659.
  • Zhang C, Wu Z, Li J-W, et al. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020;105954. DOI:10.1016/j.ijantimicag.2020.105954
  • Hällgren R, Samuelsson T, Laurent TC, et al. Accumulation of hyaluronan (Hyaluronic Acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis. 1989;139:682–687.
  • FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19. Outside of the hospital setting or a clinical trial due to risk of heart rhythm problems | FDA. FDA; 2020.
  • Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. New Engl J Med. 2020;NEJMoa2012410. DOI:10.1056/NEJMoa2012410
  • Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787–1799.
  • Maxmen A. More than 80 clinical trials launch to test coronavirus treatments. Nature. 2020;578:347–348.
  • Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395(10236):1569–1578.
  • Ortiz-Alcantara J, Bhardwaj K, Palaninathan S, et al. Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease. Virus Adapt Treat. 2010;2:125.
  • Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Pnas. 2020;117(17):9490–9496.
  • Zhao J, Hu Y, Du R, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E007.
  • Alhazzani W, Hylander Møller M, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically Ill adults with coronavirus disease 2019 (COVID-19). Critical Care Medicine. 2020;1. DOI:10.1097/CCM.0000000000004363
  • Wilson KC, Chotirmall SH, Bai C, et al. COVID-19: interim guidance on management pending empirical evidence. 2020.
  • Barratt S, Medford AR, Millar AB. Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome. Respiration. 2014;87:329–342.
  • Khoury M, Cuenca J, Cruz FF, et al. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19. Eur Respir J. 2020;2000858. DOI:10.1183/13993003.00858-2020
  • Kropf J, Grobe E, Knoch M, et al. The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal. Eur J Clin Chem Clin Biochem. 1991;29:805–812.
  • Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues using clinical-Grade Soluble Human ACE2. Cell. 2020; 181(4):905-913.e7.
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with coronavirus disease 2019 pneumonia in wuhan, china. Jama Intern Med. 2020; e200994.
  • Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-1099.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.